GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (OSTO:CMH) » Definitions » Enterprise Value

Chordate Medical Holding AB (OSTO:CMH) Enterprise Value : kr22.78 Mil (As of May. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Chordate Medical Holding AB's Enterprise Value is kr22.78 Mil. Chordate Medical Holding AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr-29.18 Mil. Therefore, Chordate Medical Holding AB's EV-to-EBIT ratio for today is -0.78.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Chordate Medical Holding AB's Enterprise Value is kr22.78 Mil. Chordate Medical Holding AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was kr-26.73 Mil. Therefore, Chordate Medical Holding AB's EV-to-EBITDA ratio for today is -0.85.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Chordate Medical Holding AB's Enterprise Value is kr22.78 Mil. Chordate Medical Holding AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.98 Mil. Therefore, Chordate Medical Holding AB's EV-to-Revenue ratio for today is 23.34.


Chordate Medical Holding AB Enterprise Value Historical Data

The historical data trend for Chordate Medical Holding AB's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB Enterprise Value Chart

Chordate Medical Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only - - - 89.33 28.82

Chordate Medical Holding AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.33 90.26 80.04 55.60 28.82

Competitive Comparison of Chordate Medical Holding AB's Enterprise Value

For the Medical Devices subindustry, Chordate Medical Holding AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chordate Medical Holding AB's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's Enterprise Value falls into.



Chordate Medical Holding AB Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Chordate Medical Holding AB's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Chordate Medical Holding AB's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chordate Medical Holding AB  (OSTO:CMH) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Chordate Medical Holding AB's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=22.782/-29.18
=-0.78

Chordate Medical Holding AB's current Enterprise Value is kr22.78 Mil.
Chordate Medical Holding AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-29.18 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Chordate Medical Holding AB's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=22.782/-26.726
=-0.85

Chordate Medical Holding AB's current Enterprise Value is kr22.78 Mil.
Chordate Medical Holding AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-26.73 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Chordate Medical Holding AB's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=22.782/0.976
=23.34

Chordate Medical Holding AB's current Enterprise Value is kr22.78 Mil.
Chordate Medical Holding AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chordate Medical Holding AB Enterprise Value Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Chordate Medical Holding AB (OSTO:CMH) Business Description

Traded in Other Exchanges
Address
c/o Regus, Kistagangen 20B, Kista, SWE, 164 40
Chordate Medical Holding AB is a medical technology company that has developed and patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients who are 18 years old or older. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB (OSTO:CMH) Headlines

No Headlines